Branislava Vojislav Daskalovic

Ms. Branislava Vojislav Daskalovic


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Branislava Vojislav DaskalovicBranislava Vojislav Daskalovic
Branislava Vojislav Daskalovic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
SBSergej Bolevic
Sergej Bolevic
MAMarijana Andjic
Marijana Andjic
JBJovana Bradic
Jovana Bradic
Jasmina SretenovicJasmina Sretenovic
Jasmina Sretenovic
Psoriasis is a chronic inflammatory skin disorder involving oxidative stress and immune dysregulation. Given the limitations and adverse effects of conventional therapies, interest in natural treatments with anti-oxidant and immunomodulatory properties is increasing. This study aimed to comprehensively evaluate the therapeutic potential of Galium verum extract in an imiquimod-induced rat model of psoriasis. The extract was chemically characterized by HPLC and evaluated for anti-oxidant activity using DPPH, ABTS, and FRAP assays. Molecular docking studies targeted psoriasis-related proteins (IL-17, IL-22, IL-23, JAK2, MAPK2, NF-κB, STAT3), revealing strong binding affinities for rutin and quercetin, the extract’s dominant bioactives. In vivo, 18 Wistar albino male rats were divided into control (CTRL), psoriasis (PSORI), and psoriasis treated with Galium verum (PSORI + GV) groups. A seven-day topical application of 5% imiquimod cream was used for the induction of psoriasis. The PSORI + GV group received 250 mg/kg Galium verum extract orally for 7 days. Morphometric and redox analyses were performed. Histological and morphometric analyses showed reduced epidermal thickness, inflammation, and collagen content. Redox analysis revealed lowered oxidative stress biomarkers and enhanced anti-oxidant defenses. These findings suggest that Galium verum extract exerts anti-psoriatic effects through antioxidative and immunomodulatory mechanisms, supporting its potential as a natural adjunct therapy for psoriasis.

29 April 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Branislava Vojislav DaskalovicBranislava Vojislav Daskalovic
Branislava Vojislav Daskalovic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
SBSergej Bolevic
Sergej Bolevic
MAMarijana Andjic
Marijana Andjic
JBJovana Bradic
Jovana Bradic
Jasmina SretenovicJasmina Sretenovic
Jasmina Sretenovic
Psoriasis is a chronic inflammatory skin disease linked to immune dysregulation and oxidative stress. Due to the limitations and side effects of conventional therapies, natural compounds are gaining increasing attention. The aim of this study was to evaluate the therapeutic potential of Melissa officinalis extract in psoriasis. HPLC analysis was used to characterize the extract, while its antioxidant activity was assessed by DPPH, ABTS, and FRAP assays. An in vivo study was conducted on 18 male Wistar albino rats divided into control (CTRL), psoriasis (PSORI), and psoriasis treated with M. officinalis (PSORI+MO) groups. Psoriasis was induced by daily topical application of 5% imiquimod cream on the shaved back skin of rats for seven constitutive days. The PSORI+MO group received M. officinalis extract orally at a dose of 200 mg/kg during seven days. Redox and inflammatory cytokine analysis were performed. Isolated skin was fixed and stained with H/E and immunohistochemical staining. Morphometric and histological analyses revealed reduced inflammation, keratinocyte proliferation, and epidermal thickness. Systemic and tissue redox status showed decreased oxidative stress biomarkers and enhanced antioxidant defense. Inflammatory cytokines (IL-17A, IL-22, IL-23, IL-1β, and IL-6) were significantly reduced. Our findings suggest that Melissa officinalis extract exerts anti-psoriatic effects through antioxidant, anti-inflammatory, and antiproliferative mechanisms.